Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel L Dries

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Heart Failure Clinics|December 1, 2009
Natriuretic peptides and the genomics of left-ventricular hypertrophyDaniel L Dries
Current Cardiology Reports|April 15, 2003
The prognostic significance of renal dysfunction in patients with chronic systolic heart failureS Raja Laskar, Daniel L Dries
Current Treatment Options in Cardiovascular Medicine|September 1, 2007
Heart failure and cardiac hypertrophyJ Eduardo Rame, Daniel L Dries
Journal of the American College of Cardiology|May 9, 2009
Genomics, transcriptional profiling, and heart failureKenneth B Margulies, Daniel P Bednarik, Daniel L Dries
Congestive Heart Failure (Greenwich, Conn.)|June 27, 2003
The prognostic value of the physical examination in patients with chronic heart failureJ Eduardo Rame, Daniel L Dries, Mark H Drazner
The American Journal of Medicine|May 3, 2003
Third heart sound and elevated jugular venous pressure as markers of the subsequent development of heart failure in patients with asymptomatic left ventricular dysfunctionMark H Drazner, J Eduardo Rame, Daniel L Dries
Congestive Heart Failure (Greenwich, Conn.)|November 6, 2008
Systolic time ratio by impedance cardiography to distinguish preserved vs impaired left ventricular systolic function in heart failureBrenda Thompson, Mark H Drazner, Daniel L Dries, et al.
Circulation. Heart Failure|September 10, 2011
Prognostic importance of early worsening renal function after initiation of angiotensin-converting enzyme inhibitor therapy in patients with cardiac dysfunctionJeffrey M Testani, Stephen E Kimmel, Daniel L Dries, et al.
Journal of the American College of Cardiology|July 11, 2002
Efficacy of angiotensin-converting enzyme inhibition in reducing progression from asymptomatic left ventricular dysfunction to symptomatic heart failure in black and white patientsDaniel L Dries, Mark H Strong, Richard S Cooper, et al.
Journal of Molecular and Cellular Cardiology|December 3, 2011
Guanylyl cyclase (GC)-A and GC-B activities in ventricles and cardiomyocytes from failed and non-failed human hearts: GC-A is inactive in the failed cardiomyocyteDeborah M Dickey, Daniel L Dries, Kenneth B Margulies, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Heart Failure Clinics|December 1, 2009
Natriuretic peptides and the genomics of left-ventricular hypertrophyDaniel L Dries
Current Cardiology Reports|April 15, 2003
The prognostic significance of renal dysfunction in patients with chronic systolic heart failureS Raja Laskar, Daniel L Dries
Current Treatment Options in Cardiovascular Medicine|September 1, 2007
Heart failure and cardiac hypertrophyJ Eduardo Rame, Daniel L Dries
Journal of the American College of Cardiology|May 9, 2009
Genomics, transcriptional profiling, and heart failureKenneth B Margulies, Daniel P Bednarik, Daniel L Dries
Congestive Heart Failure (Greenwich, Conn.)|June 27, 2003
The prognostic value of the physical examination in patients with chronic heart failureJ Eduardo Rame, Daniel L Dries, Mark H Drazner
The American Journal of Medicine|May 3, 2003
Third heart sound and elevated jugular venous pressure as markers of the subsequent development of heart failure in patients with asymptomatic left ventricular dysfunctionMark H Drazner, J Eduardo Rame, Daniel L Dries
Congestive Heart Failure (Greenwich, Conn.)|November 6, 2008
Systolic time ratio by impedance cardiography to distinguish preserved vs impaired left ventricular systolic function in heart failureBrenda Thompson, Mark H Drazner, Daniel L Dries, et al.
Circulation. Heart Failure|September 10, 2011
Prognostic importance of early worsening renal function after initiation of angiotensin-converting enzyme inhibitor therapy in patients with cardiac dysfunctionJeffrey M Testani, Stephen E Kimmel, Daniel L Dries, et al.
Journal of the American College of Cardiology|July 11, 2002
Efficacy of angiotensin-converting enzyme inhibition in reducing progression from asymptomatic left ventricular dysfunction to symptomatic heart failure in black and white patientsDaniel L Dries, Mark H Strong, Richard S Cooper, et al.
Journal of Molecular and Cellular Cardiology|December 3, 2011
Guanylyl cyclase (GC)-A and GC-B activities in ventricles and cardiomyocytes from failed and non-failed human hearts: GC-A is inactive in the failed cardiomyocyteDeborah M Dickey, Daniel L Dries, Kenneth B Margulies, et al.
Pageof 4